• Share
  • Email
  • Print

Jean-Patrice Labautière

Partner
+33.(0)1.58.44.15.47
Fax +33.(0)1.58.44.15.01

Jean-Patrice Labautière regularly advises leading corporates, financial institutions and private equity clients on the structuring, negotiation and documentation of complex acquisitions, corporate reorganisations and joint ventures involving the coordination of legal teams from different jurisdictions.

He advises on all types of corporate transactions in a practical and business oriented manner.

Mr. Labautière is particularly active in the healthcare, financial services and technology sectors.

Professional Background

Mr. Labautière started his career at a major French law firm. Prior to joining K&L Gates, Mr. Labautière spent fifteen years at Allen & Overy LLP where he practiced as a partner.

Professional/Civic Activities

  • Member of AFIC
  • Member of ACG
  • VTG in relation to the acquisition of Nacco
  • Sanofi Pasteur-MSD in relation to the termination of the joint vaccine activities of Sanofi and Merck in Europe
  • Ipsos in relation to the creation of Ipsos Partners, a management company with approx. 150 managers of the Ipsos group in the World
  • Ipsos in relation to the merger of LT Participations into Ipsos
  • Ipsos in relation to the acquisition of Synovate from Aegis
  • LT Participations in relation to subscription of FFP and Sofina to the share capital of LT Participations, the controlling shareholder of Ipsos
  • Ipsos in relation to the acquisition of OTX 
  • Ipsos in relation to the acquisition of MORI
  • Riverside Europe Partners and the founders of HRA Pharma in relation to the sale of HRA Pharma to Astorg Partners and Goldman Sachs
  • Riverside Europe Partners in relation to the acquisition of Soft Medical Europe
  • Riverside Europe Partners in relation to the sale of Orliman to Magnum Capital
  • Riverside Europe Partners in relation to its investment in HRA Pharma
  • Remedica in relation to the sale of Remedica to Ascendis
  • Oerlikon in relation to the acquisition of DMX
  • Paramount Bed in relation to the sale of Corona Medical to Galiena Capital
  • Double A, a Thai paper manufacturer, in relation to the acquisition of the Alizay site from the French State
  • Double A in relation to the acquisition of BEA from Neoen
  • Denis Payre and the other shareholders in Kiala in relation to the sale of Kiala to UPS
  • Crédit Mutuel Arkéa in relation to the creation of Arkéa Capital Partenaire, a corporate investment fund
  • WPP (Burson Marsteller) in relation to its acquisition of i&e
  • WPP (Young & Rubicam) in relation to the acquisition of Danone CRM
  • Amadeus IT Group in relation to the disposal of Amadeus Hospitality
  • Egis Projects in relation to the A63 speed road project
  • LeasePlan in relation to the sale of Services Affaires
  • LeasePlan in relation to the acquisition of Daimler Chrysler Fleet Management France
  • Oranjewoud in relation to the acquisition of Antea
  • UCB in relation to the disposal of Vogalene / Vogalib to Cephalon
  • UCB in relation to the disposal of OTC products to Laboratoires Pierre Fabre
  • Qatar National Hotels Company in relation to the acquisition of George V Eatertainment and right to use the trademarks for the world famous Buddha-Bar
  • Bank of China on its tentative acquisition of a strategic stake in Edmond de Rothschild
  • Bilfinger Berger in relation to the sale of Razel
  • TowerBrook Capital Partners in relation to the acquisition of GSE
  • TowerBrook Capital Partners in relation to the disposal of InfoPro
  • Expedia in relation to the acquisition of Egencia.com
  • Expedia in relation to the acquisition of Anyway.com
  • Heritage Partners in relation to the disposal of Diam Europe to HIG Capital 
  • FactSet in relation to the acquisition of BiSam Technologies from Aquiline Capital and management
  • FactSet in relation to the acquisition of JCF Group
  • Schlumberger in relation to the disposal of Actaris to LBO France